These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Identification and Management of Heterozygous Familial Hypercholesterolemia. Proceedings of a workshop. July 20-21, 1992. Am J Cardiol; 1993 Sep; 72(10):1D-84D. PubMed ID: 8105672 [No Abstract] [Full Text] [Related]
9. Management of familial heterozygous hypercholesterolemia. Position paper of the Polish Lipid Expert Forum. Rynkiewicz A; Cybulska B; Banach M; Filipiak KJ; Guzik T; Idzior-Waluś B; Imiela J; Jankowski P; Kłosiewicz-Latoszek L; Limon J; Myśliwiec M; Opolski G; Steciwko A; Stępińska J; Zdrojewski T Pol Arch Med Wewn; 2013; 123(1-2):7-10. PubMed ID: 23449188 [No Abstract] [Full Text] [Related]
10. Genetic risk factors in the development of heart disease: familial hypercholesterolemia and hyperhomocysteinemia. LaCharity LA AACN Clin Issues; 1998 Nov; 9(4):531-8. PubMed ID: 9855863 [TBL] [Abstract][Full Text] [Related]
11. The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association. Gidding SS; Champagne MA; de Ferranti SD; Defesche J; Ito MK; Knowles JW; McCrindle B; Raal F; Rader D; Santos RD; Lopes-Virella M; Watts GF; Wierzbicki AS; Circulation; 2015 Dec; 132(22):2167-92. PubMed ID: 26510694 [No Abstract] [Full Text] [Related]
12. Lessening the Burden of Familial Hypercholesterolemia Using Health Information Technology. Safarova MS; Kullo IJ Circ Res; 2018 Jan; 122(1):26-27. PubMed ID: 29301842 [No Abstract] [Full Text] [Related]
13. Familial hypercholesterolemia. There is a need for early detection and treatment. Bilheimer DW JAMA; 1987 Jan; 257(1):69-70. PubMed ID: 3783906 [No Abstract] [Full Text] [Related]